{"product_id":"xolid-100mg-suspension-broad-spectrum-oxazolidinone-antibacterial-therapy","title":"Xolid 100mg Suspension - Broad-Spectrum Oxazolidinone Antibacterial Therapy","description":"\u003cdiv class=\"container\"\u003e\r\\n\u003cdiv id=\"model-response-message-contentr_9260f2b72ed2f63e\" class=\"markdown markdown-main-panel md-content enable-luminous-fast-follows enable-updated-hr-color tutor-markdown-rendering\" dir=\"ltr\" aria-busy=\"false\" aria-live=\"polite\"\u003e\r\\n\u003ch2 data-path-to-node=\"9\"\u003eProduct Overview\u003c\/h2\u003e\r\\n\u003cp data-path-to-node=\"10\"\u003e\u003cb data-path-to-node=\"10\" data-index-in-node=\"0\"\u003eXolid 100mg Suspension\u003c\/b\u003e (100mg per 5ml) is a synthetic, broad-spectrum oxazolidinone antibacterial formulation containing \u003cb data-path-to-node=\"10\" data-index-in-node=\"121\"\u003eLinezolid\u003c\/b\u003e. Specially formulated as an oral liquid suspension, Xolid is engineered for pediatric administration and adult patients who have difficulty swallowing solid oral dosage forms. It is indicated for the treatment of severe, complicated Gram-positive bacterial infections, including \u003cb data-path-to-node=\"10\" data-index-in-node=\"410\"\u003eMethicillin-Resistant \u003ci data-path-to-node=\"10\" data-index-in-node=\"432\"\u003eStaphylococcus aureus\u003c\/i\u003e (MRSA)\u003c\/b\u003e, \u003cb data-path-to-node=\"10\" data-index-in-node=\"462\"\u003eVancomycin-Resistant \u003ci data-path-to-node=\"10\" data-index-in-node=\"483\"\u003eEnterococcus faecium\u003c\/i\u003e (VRE)\u003c\/b\u003e, nosocomial and community-acquired pneumonia, and complicated skin and skin structure infections.\u003c\/p\u003e\r\\n\r\\n\u003ch3 data-path-to-node=\"11\"\u003eKey Benefits\u003c\/h3\u003e\r\\n\u003cul data-path-to-node=\"12\"\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"12,0,0\"\u003e\u003cb data-path-to-node=\"12,0,0\" data-index-in-node=\"0\"\u003eTargeted Activity Against Multi-Drug Resistant Gram-Positives:\u003c\/b\u003e Highly effective against resistant pathogens, including MRSA, VRE, and penicillin-resistant \u003ci data-path-to-node=\"12,0,0\" data-index-in-node=\"155\"\u003eStreptococcus pneumoniae\u003c\/i\u003e.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"12,1,0\"\u003e\u003cb data-path-to-node=\"12,1,0\" data-index-in-node=\"0\"\u003eHigh Oral Bioavailability:\u003c\/b\u003e Provides near 100% oral bioavailability, allowing seamless transition from intravenous Linezolid therapy to oral outpatient care.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"12,2,0\"\u003e\u003cb data-path-to-node=\"12,2,0\" data-index-in-node=\"0\"\u003ePatient-Friendly Liquid Delivery:\u003c\/b\u003e Designed for pediatric, elderly, and dysphagic patients requiring precise weight-based dosing.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"12,3,0\"\u003e\u003cb data-path-to-node=\"12,3,0\" data-index-in-node=\"0\"\u003eUnique Mechanism of Action:\u003c\/b\u003e Minimal risk of cross-resistance with other established antibiotic classes due to its early-stage protein synthesis inhibition.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"12,4,0\"\u003e\u003cb data-path-to-node=\"12,4,0\" data-index-in-node=\"0\"\u003eEffective Tissue Penetration:\u003c\/b\u003e Rapidly distributes into lung, bone, and soft tissue structures for optimal clinical resolution.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n\u003c\/ul\u003e\r\\n\u003ch3 data-path-to-node=\"13\"\u003eHow It Works\u003c\/h3\u003e\r\\n\u003cp data-path-to-node=\"14\"\u003eXolid 100mg Suspension (Linezolid) exerts its bactericidal and bacteriostatic effects by inhibiting bacterial protein synthesis at an earlier stage than most other antibiotics. It selectively binds to the \u003cb data-path-to-node=\"14\" data-index-in-node=\"205\"\u003e23S ribosomal RNA\u003c\/b\u003e of the 50S subunit of the bacterial ribosome. This action prevents the assembly of the functional \u003cb data-path-to-node=\"14\" data-index-in-node=\"321\"\u003e70S initiation complex\u003c\/b\u003e, which is essential for translating messenger RNA (mRNA) into bacterial proteins. By halting protein production early, Xolid inhibits bacterial replication and halts infection progression.\u003c\/p\u003e\r\\n\r\\n\u003ch3 data-path-to-node=\"15\"\u003eKey Active Ingredients\u003c\/h3\u003e\r\\n\u003cul data-path-to-node=\"16\"\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"16,0,0\"\u003e\u003cb data-path-to-node=\"16,0,0\" data-index-in-node=\"0\"\u003eLinezolid (100mg per 5ml reconstituted suspension):\u003c\/b\u003e Synthetic oxazolidinone antibacterial agent that blocks bacterial 70S ribosomal initiation.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n\u003c\/ul\u003e\r\\n\u003ch3 data-path-to-node=\"17\"\u003eDirections for Use\u003c\/h3\u003e\r\\n\u003col start=\"1\" data-path-to-node=\"18\"\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"18,0,0\"\u003e\u003cb data-path-to-node=\"18,0,0\" data-index-in-node=\"0\"\u003eReconstitution (if supplied as dry powder):\u003c\/b\u003e Tap the bottle to loosen powder. Add the specified volume of cooled, boiled water in two portions, shaking vigorously after each addition until a uniform suspension is formed.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"18,1,0\"\u003e\u003cb data-path-to-node=\"18,1,0\" data-index-in-node=\"0\"\u003eAdministration:\u003c\/b\u003e Shake the bottle thoroughly before each dose. Measure the exact dose using a calibrated oral dosing syringe or measuring spoon.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"18,2,0\"\u003e\u003cb data-path-to-node=\"18,2,0\" data-index-in-node=\"0\"\u003eDosing:\u003c\/b\u003e\u003c\/p\u003e\r\\n\r\\n\u003cul data-path-to-node=\"18,2,1\"\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"18,2,1,0,0\"\u003e\u003cb data-path-to-node=\"18,2,1,0,0\" data-index-in-node=\"0\"\u003ePediatric Patients (Infants and Children up to 11 years):\u003c\/b\u003e Typically 10mg\/kg administered orally every 8 hours.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"18,2,1,1,0\"\u003e\u003cb data-path-to-node=\"18,2,1,1,0\" data-index-in-node=\"0\"\u003eAdults and Adolescents (12 years and older):\u003c\/b\u003e Typically 600mg (30ml) administered orally every 12 hours, or as prescribed by the attending physician.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n\u003c\/ul\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"18,3,0\"\u003e\u003cb data-path-to-node=\"18,3,0\" data-index-in-node=\"0\"\u003eFood Intake:\u003c\/b\u003e May be taken with or without food.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n\u003c\/ol\u003e\r\\n\u003ch3 data-path-to-node=\"19\"\u003ePrecautions\u003c\/h3\u003e\r\\n\u003cul data-path-to-node=\"20\"\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"20,0,0\"\u003e\u003cb data-path-to-node=\"20,0,0\" data-index-in-node=\"0\"\u003ePrescription-Only Medication:\u003c\/b\u003e Administer strictly under the supervision and guidance of a licensed medical practitioner.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"20,1,0\"\u003e\u003cb data-path-to-node=\"20,1,0\" data-index-in-node=\"0\"\u003eMonoamine Oxidase (MAO) Inhibition Warning:\u003c\/b\u003e Linezolid is a reversible, non-selective MAO inhibitor. Avoid concomitant use with serotonergic drugs (SSRIs, SNRIs, tricyclic antidepressants) to prevent serotonin syndrome, and avoid consumption of large amounts of tyramine-rich foods (e.g., aged cheeses, fermented meats, red wine).\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"20,2,0\"\u003e\u003cb data-path-to-node=\"20,2,0\" data-index-in-node=\"0\"\u003eHematologic Monitoring:\u003c\/b\u003e Reversible myelosuppression (anemia, leukopenia, pancytopenia, and thrombocytopenia) has been reported, particularly with courses exceeding 14 days. Complete blood counts (CBC) should be monitored weekly during extended therapy.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"20,3,0\"\u003e\u003cb data-path-to-node=\"20,3,0\" data-index-in-node=\"0\"\u003ePeripheral \u0026amp; Optic Neuropathy:\u003c\/b\u003e Reported primarily in patients treated for longer than 28 days. Discontinue and evaluate if visual impairment or numbness occurs.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"20,4,0\"\u003eConsult a physician prior to use during pregnancy or lactation.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n \t\u003cli\u003e\r\\n\u003cp data-path-to-node=\"20,5,0\"\u003eKeep out of reach of children.\u003c\/p\u003e\r\\n\u003c\/li\u003e\r\\n\u003c\/ul\u003e\r\\n\u003ch3 data-path-to-node=\"21\"\u003eStorage Instructions\u003c\/h3\u003e\r\\n\u003cp data-path-to-node=\"22\"\u003eStore dry powder and reconstituted suspension in a cool, dry place below 30°C, protected from direct sunlight and heat. Do not freeze. Keep the bottle tightly closed after each use, and discard any unused reconstituted suspension after 21 days (or as specified on the package label).\u003c\/p\u003e\r\\n\r\\n\u003ch3 data-path-to-node=\"23\"\u003eManufacturer Information\u003c\/h3\u003e\r\\n\u003cp data-path-to-node=\"24\"\u003eFormulated and manufactured in strict compliance with international pharmaceutical quality standards, dedicated to producing advanced anti-infective formulations that effectively combat resistant bacterial pathogens and protect patient health.\u003c\/p\u003e\r\\n\r\\n\u003c\/div\u003e\r\\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":44164491116603,"sku":null,"price":440.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0695\/4899\/8715\/files\/XOLID-SYP.jpg?v=1789027898","url":"https:\/\/pharmaservicesgroup.com\/products\/xolid-100mg-suspension-broad-spectrum-oxazolidinone-antibacterial-therapy","provider":"Pharma Services Distribution","version":"1.0","type":"link"}